RVMD drug approval chatter; SLS leukemia pipeline focus
TradingView News says market attention is on RVMD’s drug approval, while near-term focus remains on SLS’s leukemia pipeline.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.